Antiviral antibiotic BU-3889V

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Conjugate or complex

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514 25, 424114, 424115, 424116, 424117, 424 858, A61K 3710, A61K 31395, C12P 1718

Patent

active

050987089

ABSTRACT:
Production of an antiviral antibiotic complex, BU-3889V and its bioactive components A.sub.1, A.sub.2, A.sub.3, D.sub.1, D.sub.2 and D.sub.3, by fermentation of a BU-3889V producing strain of the new microorganism Amycolatopsis orientalis ATCC-53884 is disclosed. Complex BU-3889V is recovered and the components separated by the use of ion exchange chromatography techniques. The bioactive components are characterized by their physico-chemical characterizing properties. The products have been found to be effective to inhibit viruses including herpes simplex virus, human immunodeficiency virus (HIV) and influenza virus.

REFERENCES:
patent: 4675187 (1987-06-01), Konishi et al.
patent: 4916065 (1990-04-01), Ohkuma et al.
patent: 4960755 (1990-10-01), Nishio et al.
Sandstrom et al., Anti-Viral Therapy in AIDS, AIDS Press Limited, pp. 373-390, 1987.
Mitsuya et al., Retroviruses in Human Lymphoma/Leukemia, "Protection of T Cells Against Infectivity and Cytopathic Effect of HTLV-III in Vitro", pp. 277-288, 1985.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Antiviral antibiotic BU-3889V does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antiviral antibiotic BU-3889V, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiviral antibiotic BU-3889V will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2008853

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.